Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9603 posts found.

Bristol-Myers Squibb elects Gerald Storch to board of directors

January 26, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing BMS, Gerald Storch

Bristol-Myers Squibb has announced that its board has elected Gerald Storch to serve as a member of the audit committee, …
Appointment

CRAs spend less time on site, more time travelling

January 25, 2012 Research and Development CRAs, Clinical Research Associates, Tufts, clinical trials

A new study of how clinical research associates (CRAs) spend their time has produced some interesting and surprising results. The …
News

Cell-based assays to help speed toxicity studies

January 25, 2012 Research and Development Qiagen, cell-based assays, drug discovery

Use of cell-based assay technology is set to grow rapidly over the next decade, helping to speed up drug discovery …
News
Roche picture

Roche launches $5.7 billion hostile bid for Illumina

January 25, 2012 Research and Development, Sales and Marketing Diagnostics, Illumina, Roche

Roche has launched a hostile takeover bid for US diagnostics company Illumina. The Swiss manufacturer appears tired of waiting for …
News

Premier Research appoints Etienne Drouet as executive director, Oncology Europe

January 25, 2012 Business Services, Research and Development, Sales and Marketing Etienne Drouet, Premier Research

 Premier Research Group has announced the appointment of Etienne Drouet to the position of executive director, Oncology Europe.In this position, …
Appointment

Gates urges investment in innovations for developing nations

January 25, 2012 Research and Development AIDS, Bill Gates, Global Fund, TB, malaria

Bill Gates has called on global leaders to invest in innovations that are accelerating progress against poverty, or risk a …
News
Lansley picture

Councils given £2.2 billion for public health

January 25, 2012 Research and Development, Sales and Marketing Lansley, NHS, public health outcomes framework

The government’s new vision for public health has come under fire from observers worried that accountability for the strategy remains …
News

MHRA Inspections of CROs

January 24, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Audits, Wainwright Associates, inspectons

In accordance with the provisions of the new pharmacovigilance legislation, as per Directive 2010/84/EU, EU Competent Authorities may inspect the …
News
Press release

Moving towards milestones: the evolving pharma – biotech relationship

January 24, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Deals, Susan Aldridge, biotech, pharma

Big pharma is going through the greatest ever wave of patent expiries, while small biotechs are finding it hard to …
Feature

Richard Barker elected to Celgene’s board of directors

January 24, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing ABPI, Celgene, Richard Barker

Celgene, the biopharma firm specialising in cancer and inflammatory diseases, has elected Richard Barker to its board of directors. Dr …
Appointment

Alnylam cuts workforce by a third

January 23, 2012 Research and Development, Sales and Marketing Alnylam, Novartis, job cuts, rnai

Alnylam will cut 33% of its workforce this year as it looks to focus on developing its own products. The …
News

Contract research news in brief

January 23, 2012 Research and Development CoreLab Partners and Acurian, Quintiles, vivoPharma

Quintiles invests in new biomarket firm and sets up a new office in China, plus updates from vivoPharma, CoreLab Partners …
News

Payment changes of authority’s fees in France

January 20, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates, regulatory affairs

Changes are being made in the way fees are paid for regulatory submissions and procedures in France.  Fees are no …
News
Press release

Novartis’ Signifor recommended in Europe

January 20, 2012 Research and Development, Sales and Marketing CHMP, Cushing's disease, Novartis, Signifor

A European committee has recommended Novartis’ Signifor for the treatment of a rare, debilitating endocrine disorder. The European Committee for …
News
Gilenya image

EMA to review safety of MS drug Gilenya

January 20, 2012 Research and Development, Sales and Marketing CHMP, EMA, Novartis, gilenya

The European Medicines Agency has begun a review into the safety of Novartis’ multiple sclerosis drug Gilenya. This follows concerns …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026